Suppr超能文献

获得性C1抑制物缺乏症伴肾病综合征。

Acquired C1-inhibitor deficiency presenting with nephrotic syndrome.

作者信息

Willows Jamie, Wood Katrina, Bourne Helen, Sayer John Andrew

机构信息

Renal Services, Freeman Hospital, Newcastle upon Tyne, UK.

Histopathology Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK.

出版信息

BMJ Case Rep. 2019 Jul 11;12(7):e230388. doi: 10.1136/bcr-2019-230388.

Abstract

Acquired C1-inhibitor (C1-INH) deficiency is a rare and potentially life-threatening disorder, which presents with recurrent attacks of non-pitting oedema to the face, airway, limbs or gastrointestinal tract. It is often associated with underlying B-cell lymphoproliferative disorders. We describe a case of a 73-year-old man with acquired C1-INH deficiency who presented with nephrotic syndrome due to glomerular IgM deposition, secondary to an underlying secretory lymphoplasmacytic lymphoma. Both the acquired C1-INH deficiency and the nephrotic syndrome resolved when the underlying B-cell lymphoma was treated with rituximab and bendamustine, suggesting the underlying lymphoproliferative malignancy was driving both disorders.

摘要

获得性C1抑制物(C1-INH)缺乏症是一种罕见且可能危及生命的疾病,表现为面部、气道、四肢或胃肠道反复出现非凹陷性水肿。它常与潜在的B细胞淋巴增殖性疾病相关。我们描述了一例73岁男性获得性C1-INH缺乏症患者,该患者因潜在的分泌性淋巴浆细胞淋巴瘤继发肾小球IgM沉积而出现肾病综合征。当用利妥昔单抗和苯达莫司汀治疗潜在的B细胞淋巴瘤时,获得性C1-INH缺乏症和肾病综合征均得到缓解,这表明潜在的淋巴增殖性恶性肿瘤是导致这两种疾病的原因。

相似文献

1
Acquired C1-inhibitor deficiency presenting with nephrotic syndrome.
BMJ Case Rep. 2019 Jul 11;12(7):e230388. doi: 10.1136/bcr-2019-230388.
3
An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation.
J Cutan Pathol. 2020 Sep;47(9):850-853. doi: 10.1111/cup.13722. Epub 2020 Jul 17.
8
Renal involvement in Waldenström's macroglobulinemia: case report and review of literature.
Ren Fail. 2014 Feb;36(1):114-8. doi: 10.3109/0886022X.2013.832859. Epub 2013 Sep 24.
9
Cases of acquired C1 inhibitor deficiency treated with rituximab.
J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):987-8. doi: 10.1016/j.jaip.2016.02.019. Epub 2016 Apr 27.
10
Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship.
Crit Rev Oncol Hematol. 2013 Sep;87(3):323-32. doi: 10.1016/j.critrevonc.2013.02.004. Epub 2013 Mar 13.

引用本文的文献

1
variants contribute to FSGS susceptibility across multiple populations.
iScience. 2025 Mar 18;28(4):112234. doi: 10.1016/j.isci.2025.112234. eCollection 2025 Apr 18.
2
variants contribute to FSGS susceptibility across multiple populations.
medRxiv. 2023 Nov 20:2023.11.20.23298462. doi: 10.1101/2023.11.20.23298462.

本文引用的文献

1
Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
J Allergy Clin Immunol Pract. 2017 Sep-Oct;5(5):1307-1313. doi: 10.1016/j.jaip.2016.12.032. Epub 2017 Mar 9.
3
Angioedema related to Angiotensin inhibitors.
J Pharm Pract. 2014 Oct;27(5):461-5. doi: 10.1177/0897190014546101. Epub 2014 Aug 14.
4
A UK national audit of hereditary and acquired angioedema.
Clin Exp Immunol. 2014 Jan;175(1):59-67. doi: 10.1111/cei.12159.
5
Acquired C1-inhibitor deficiency: 7 patients treated with rituximab.
J Clin Immunol. 2012 Oct;32(5):936-41. doi: 10.1007/s10875-012-9691-2. Epub 2012 Apr 20.
6
New topics in bradykinin research.
Allergy. 2011 Nov;66(11):1397-406. doi: 10.1111/j.1398-9995.2011.02686.x. Epub 2011 Aug 22.
7
Acquired angioedema.
Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):14. doi: 10.1186/1710-1492-6-14.
8
The spectrum of chronic angioedema.
Allergy Asthma Proc. 2009 Jan-Feb;30(1):11-6. doi: 10.2500/aap.2009.30.3188.
9
Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
Autoimmun Rev. 2008 Dec;8(2):156-9. doi: 10.1016/j.autrev.2008.05.003. Epub 2008 Jun 12.
10
Membranous nephropathy in a patient with hereditary angioedema: a case report.
J Med Case Rep. 2008 Oct 13;2:328. doi: 10.1186/1752-1947-2-328.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验